Codagenix Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $20M
Latest Deal Amount
  • Investors
  • 11

Codagenix General Information

Description

Developer of live-attenuated viral vaccines intended to provide target antigens placed in an attenuated backbone virus. The company's vaccines use Synthetic Attenuated Virus Engineering (SAVE), which are based on synthetic biology and are rationally re-designed for the entire genome to yield a vaccine strain, enabling researchers to invent viral vaccine to treat influenza, dengue, polio, and other diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 3 Bioscience Park Drive
  • Farmingdale
  • New York, NY 11735-0176
  • United States
+1 (631) 000-0000

Codagenix Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Codagenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 13-Jan-2020 $20M 0000 0000 Completed Clinical Trials - Phase 1
9. Grant 15-Apr-2019 00000 00.000 Completed Startup
8. Later Stage VC 00.00 00.000 000.00 Completed Startup
7. Later Stage VC 12-Oct-2017 00.00 00.000 0000 Completed Startup
6. Grant 12-Oct-2017 00.000 00.000 Completed Startup
5. Early Stage VC (Series A3) 13-Oct-2016 000 00.000 0000 Completed Startup
4. Early Stage VC (Series A2) 12-Jun-2015 000 00.000 000 Completed Startup
3. Accelerator/Incubator 04-Mar-2015 0000 Completed Startup
2. Accelerator/Incubator 16-Dec-2014 $100K $50K Completed Startup
1. Grant 01-Jun-2012 $600K Completed Startup
To view Codagenix’s complete valuation and funding history, request access »

Codagenix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A5 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A4 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.00
Series A3 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A2 3,619,189 $0.000010 6% $0.55 $0.55 1x $0.55 12.47%
Series A1 187,266 $0.000010 6% $0.27 $0.27 1x $0.27 0.65%
To view Codagenix’s complete cap table history, request access »

Codagenix Executive Team (4)

Name Title Board Seat Contact Info
J. Coleman Ph.D Co-Founder, Chief Executive Officer & Board Member
Steffen Mueller Ph.D Co-Founder, President, Chief Scientific Officer & Board Member
Eckard Wimmer Co-Founder & Board Member
Sybil Tasker MD Chief Medical Officer
To view Codagenix’s complete executive team members history, request access »

Codagenix Board Members (5)

Name Representing Role Since
Charlie Petty Codagenix Board Member 000 0000
Eckard Wimmer Codagenix Co-Founder & Board Member 000 0000
Glenn Rockman Self Board Member 000 0000
J. Coleman Ph.D Codagenix Co-Founder, Chief Executive Officer & Board Member 000 0000
Steven Winick JD Self Board Member 000 0000
To view Codagenix’s complete board members history, request access »

Codagenix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Codagenix Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adjuvant Capital Impact Investing Minority 000 0000 000000 0
Euclidean Capital Other Minority 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
Small Business Innovation Research Government 000 0000 000000 0
United States Department of Agriculture Government 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »